Name Tablets of white color, flat-cylindrical, with a notch and a chamfer. Composition One tablet contains: active substance – calcium gluconate – 500 mg, excipients – potato starch, talc, magnesium stearate, anhydrous colloidal silicon dioxide. Pharmacotherapeutic group Calcium preparations. ATX code: A12AA03. Pharmacological properties Pharmacodynamics Normalizes calcium metabolism in the body. Pharmacokinetics In the gastrointestinal tract, about one third of the calcium consumed is absorbed, mainly in the small intestine. 99% of calcium in the body is concentrated in the solid structures of bones and teeth, the rest -1% – in the intra- and extracellular fluid. Calcium is found in the blood in both free (ionized) and bound forms. Calcium is excreted in faeces, urine and sweat. Indications for use Prevention and treatment of calcium deficiency; replenishment of calcium requirements as an adjunct to specific therapy for osteoporosis in patients at risk of calcium deficiency. Contraindications hypersensitivity to the active substances or to any of the excipients; severe renal failure; active form of tuberculosis; hypercalcemia or hypercalciuria; nephrolithiasis. Dosage and administration Assign inside, before eating. The tablet must be crushed or chewed before swallowing. Use in adults: with calcium deficiency: one tablet 1-3 times a day; additional therapy for osteoporosis: one tablet 1-3 times a day. Use in children: with calcium deficiency: one tablet 1-2 times a day. Use in persons with impaired renal function. Use in patients with severe renal impairment is not recommended. No special dose adjustment or frequency of use is required in patients with moderate to moderate renal impairment. Use in persons with impaired liver function. No special dose adjustment or frequency of use is required in patients with impaired liver function. Use in the elderly. The dose is the same as for adults. A possible decrease in creatinine clearance should be taken into account. The duration of use for the prevention and treatment of calcium deficiency is determined by the doctor and averages from ten days to one and a half months. Adverse reactions Adverse reactions are listed according to the classification of undesirable adverse reactions in accordance with the damage to organs and organ systems and the frequency of development. Metabolic and nutritional disorders Uncommon: hypercalcemia and hypercalciuria. Very rare: milk-alkaline syndrome (usually only in case of overdose). From the gastrointestinal tract Rarely: mild gastrointestinal disorders: constipation, diarrhea. Very rare: dyspepsia. Skin and subcutaneous tissue disorders Very rare: pruritus, rash, urticaria. Since the cardiovascular system Possible cardiac arrhythmias and bradycardia. Precautions Calcium preparations should be used with caution in patients with heart disease or sarcoidosis. Careful monitoring of the amount of calcium in the blood, calcium excretion in the urine is necessary when prescribing high doses of the drug, especially in children. Treatment should be stopped if the blood calcium level exceeds 2.625–2.75 mmol/l or if urinary calcium excretion exceeds 5 mg/kg. Patients with mild hypercalciuria, a decrease in glomerular filtration rate, or a history of nephrolithiasis should be prescribed with caution and under the control of calcium in the urine. Caution should be exercised in patients who simultaneously use other vitamin-mineral complexes, due to the possible presence of calcium in their composition, which can lead to its overdose. Use during pregnancy and lactation Pregnant women who take calcium supplements in conjunction with vitamin D increase the likelihood of developing hypercalcemia. In the recommended doses, taking calcium supplements does not cause any negative consequences for the fetus; it is also safe to use when breastfeeding. Influence on the ability to drive cars and mechanisms Does not affect. Overdose Deliberate overdose is unlikely. Symptoms: anorexia, muscle weakness, nausea, vomiting, headache, intense thirst, dizziness, increased blood urea. Calcium can be deposited in the kidneys, arterial walls. Milk-alkaline syndrome may occur in patients who take large amounts of calcium or absorbable alkaline foods orally. Symptoms: frequent urination, prolonged headache, loss of appetite, nausea, vomiting, weakness, hypercalcemia, renal failure. Treatment: minimization of calcium intake, withdrawal of drugs that promote hypercalcemia (thiazides, vitamin D), correction of dehydration and electrolyte imbalance, if necessary, the appointment of loop diuretics (furosemide). In severe cases, a significant amount of calcium can be removed by peritoneal dialysis. Patients with symptoms of overdose should avoid exposure to direct sunlight. In the treatment of calcium overdose, special attention should be paid to patients with impaired renal function. Upakovka10 tablets in a blister pack of PVC film and aluminum foil. 10 tablets in a contoured non-cell package made of polymer-coated paper or a combination of paper and cardboard-based material. 1 or 5 blisters or non-cell packs, together with a leaflet, are placed in a cardboard pack (No. 10×1, No. 10×5). 390 blisters or 300 blisters with 10 instructions for use are placed in a cardboard box (No. 10×390, No. 10×300). Storage conditions In a place protected from moisture, at a temperature not exceeding 25 ° C. Keep out of the reach of children. Shelf life 5 years. Do not use after the expiration date. Terms of dispensing from pharmaciesWithout a prescription. Buy Calcium gluconate tablets 500mg No. 10×5 Price for Calcium gluconate tablets 500mg No. 10×5
INN | CALCIUM GLUCONATE |
---|---|
The code | 72 572 |
Barcode | 4 810 201 004 433 |
Dosage | 500mg |
Active substance | calcium gluconate |
Manufacturer | Borisov plant of medical preparations, Belarus |
Indications Applications | prevention and treatment of calcium deficiency; replenishment of calcium requirements as an adjunct to specific therapy for osteoporosis in patients at risk of calcium deficiency. |
Contraindications | hypersensitivity to the active substances or to any of the excipients; severe renal failure; active form of tuberculosis; hypercalcemia or hypercalciuria; nephrolithiasis. |
Side effects | Adverse reactions are listed according to the classification of undesirable adverse reactions in accordance with the damage to organs and organ systems and the frequency of development. Metabolic and nutritional disorders Uncommon: hypercalcemia and hypercalciuria. Very rare: milk-alkaline syndrome (usually only in case of overdose). From the gastrointestinal tract Rarely: mild gastrointestinal disorders: constipation, diarrhea. Very rare: dyspepsia. Skin and subcutaneous tissue disorders Very rare: pruritus, rash, urticaria. Since the cardiovascular system Possible cardiac arrhythmias and bradycardia. |
Use during pregnancy and lactation | Can be used |
Application Gender | Any |
Release Form | tablets |
Main Active Substances | calcium gluconate |
Composition Means | active substance – calcium gluconate – 500 mg, excipients – potato starch, talc, magnesium stearate, anhydrous colloidal silicon dioxide. |
Reviews
There are no reviews yet.